Ovizio Imaging Systems announces iLine F and BioConnect supply agreements with Celgene Corporation

Brussels, Belgium 22/10/2019 – Ovizio Imaging Systems, a company providing an innovative microscopic imaging technology to the bioprocessing market, today announces the execution of supply agreements with Celgene Corporation for the automation of certain engineered T cell manufacturing processes.

Celgene will be using Ovizio’s innovative on-line iLine F microscope, and the BioConnect system, a closed, single-use fluidic sampling system, to further automate the manufacturing of engineered T-cell investigational products and improve product control across their global manufacturing network. These agreements follow a technology development cooperative effort initiated in 2018.

Emilie Viey, CEO of Ovizio Imaging Systems: “We are proud to support Celgene’s efforts in cell therapy, developing innovative programs for patients in areas of high unmet need. As a supportive technology partner, we are excited for the opportunities ahead as we continue our work with Celgene, seamlessly integrating Ovizio’s innovative microscopy solution into their engineered T-cell products manufacturing process.”

About Ovizio Imaging Systems
Ovizio Imaging Systems, founded in 2009, develops and commercializes a quantitative microscopic imaging platform technology based on patented Differential Digital Holographic Microscopy (DDHM). Ovizio is establishing its footprint in the Bioprocessing market, with a focus on Cell and Gene Therapy and Vaccine production.

About the iLine F microscope
The iLine F microscope uses a unique Holograms-based method, for on-line, non-invasive, and label-free suspension cell counting and classification. Combined with a bioreactor, it continuously tracks objects in real-time and, at a single cell level; with high accuracy and enables automation of current manual processes.

About the Bioconnect Single Use System
The BioConnect is a single-use disposable and autoclavable closed loop fluidics system, which is specifically designed with a cell-friendly membrane pump working like a heart. Thanks to an automatic and continuously flushing, cells flow through the imaging device and flow back to the bioreactor after holograms of the cells have been captured.
 

Media Contact

Emilie Viey, PhD
CEO of Ovizio Imaging Systems
emilie.viey@ovizio.com

Rue du Bourdon 100/2
1180 Brussels, BELGIUM
T +32 2 600 50 94


Science for Health 2019

Ovizio will be joining Science for Health 2019, taking place on Wednesday Sep. 11 in Brussels. Feel free to meet us for interesting discussions and new insights. More info can be found here


CAR-TCR Summit 2019, Sep. 10-13, Boston

CEO Emilie Viey and VP Sales & Marketing Jan Van Hauwermeiren will be representing Ovizio during the CAR-TCR Summit 2019. Come to our booth #19 or learn all about our technology during the Tech slam on Wednesday Sep. 11 at 4.20pm.

For the full agenda of the conference, click here


WEBINAR: Automated, Closed-Loop, Inline Monitoring of CAR-T Cells in a Production Process

Please join us on Thursday August 29 at 11h00 EDT/17h00 CET for the latest updates on the advantages of using 3D holographic imaging and machine learning to monitor your CAR-T cells.

Register here


Ovizio’s team is growing in Artificial Intelligence and Business Development!

Ovizio is happy to announce that it has hired 2 new team members.

Damien Cabosart joined Ovizio as Data Scientist in order to reinforce our Software Development team. Damien holds a M.Sc. in Physics from the Université de Namur, and a PhD in Engineering Sciences from the Université Catholique de Louvain. He made a postdoc at Delft University of Technology to develop machine learning tools as a Data Scientist researcher. He brings to Ovizio machine learning expertise and will support the continued development of our software suite OsOne.

Pascale Charbonnel joined Ovizio as Senior Business Developer. She holds a PhD in Molecular Microbiology Sciences from the Université de Paris XI – Orsay. Pascale has been working in the Health Industry for 19 years (Animal & Human Health). She brings to Ovizio international business development & alliance management with strategic pharma accounts. We’re glad to welcome her to develop and enrich our presence in the cell therapy and vaccine industries.

We warmly welcome Damien and Pascale in our team!


The new BioConnect design

Proud to present this application note, showcasing the improvements we’ve made to the BioConnect! As bioreactors evolve, we’ve kept pace to deliver an interface between any cell cultivation vessel and our Ovizio microscopes. The updates BioConnect design means this disposable, single-use connector is now suitable for all types of bioreactors and can provide you with a sterile, closed-loop system for real-time cell monitoring.


READ MORE


Bioprocessing Summit Europe, Lisboa, March 19-21

Come visit us at the Bioprocessing Summit Europe the following days. While you are here, enjoy the talk by  about the use of Ovizio's technology in large scale production of vaccines for the in real time monitoring of viral infection kinetics. Set your agenda on Tuesday March 19 at 12h00.